跳至主要内容
临床试验/ISRCTN55725285
ISRCTN55725285已完成未知

A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomised study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design.

Solvay Pharmaceuticals (Germany)0 个研究点目标入组 0 人开始时间: 2004年10月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

研究设计

研究类型
Interventional

入排标准

入选标准

  • Investigative centers from eight European countries and Canada (primary and secondary care) targeting patients with grade I - II hypertension and associated diabetes mellitus type 2. Goal blood pressure (BP) targeted: below 130/80 mmHg.

排除标准

  • Not provided at time of registration

研究者

发起方
Solvay Pharmaceuticals (Germany)

相似试验

A novel approach to treatment of hypertension in... | 临床试验